www.encognitive.com ONE of Australia's most senior cancer specialists has accused pharmaceutical companies of manipulating some clinical trials of medicines for commercial reasons, including deliberately delaying the release of negative findings and being reluctant to fund research into the toxicity of their drugs. Professor Stephen Clarke, who has conducted clinical trials ...